Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A1 | O15245 | 4/20 | 0.92 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.79 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.69 |
| ▸ | TP53 | P04637 | 1/20 | 0.69 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.69 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.69 |
| ▸ | TSHR | P16473 | 1/20 | 0.69 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.69 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.69 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.69 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.61 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrabuthylammonium SCHEMBL27592181 | 0.96 | SLC22A1 (0.86) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL4056557 | 0.96 | SLC22A1 (0.86) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL28299909 | 0.96 | SLC22A1 (0.86) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL22384 | 0.96 | SLC22A1 (1.00) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL71525 | 0.96 | SLC22A1 (1.00) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL2007037 | 0.96 | SLC22A1 (1.00) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL27625046 | 0.93 | SLC22A1 (0.80) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL5949329 | 0.93 | SLC22A1 (0.80) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL25266692 | 0.92 | SLC22A1 (0.92) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL5069703 | 0.92 | SLC22A1 (0.92) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2287 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122091514-A | Negative electrode material for packaging tin phosphide by using few-layer MXene curling and preparation method thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-122079717-A | Efficient oxygen deleting reagent and application thereof in carbon resource molecular skeleton deoxidizing reconstruction | — | 2026-05-26 | — | — | CN | claimed |
| US-12582977-B2 | Noble metal nanocluster catalysts for oxygen evolution reaction and water splitting system using the same | SK INNOVATION CO., LTD. (KR) | 2026-03-24 | — | — | US | claimed |
| US-12545680-B2 | Substituted oxaspiro[4.5]decanes as mor receptor agonists | SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) | 2026-02-10 | — | — | US | claimed |
| US-12540138-B2 | Substituted oxaspiro[4.5]decanes as MOR receptor agonists | SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) | 2026-02-03 | — | — | US | claimed |
| US-20250257220-A1 | METHOD FOR PREPARING A COLORED PARTICULATE MATERIAL BY HETEROGENEOUS NUCLEATION | UGIEL (FR) | 2025-08-14 | — | — | US | claimed |
| CN-116426007-B | Preparation method and application of synergistic antibacterial antiviral deodorizing master batch | 浙江理工大学桐乡研究院有限公司 | 2025-05-30 | — | — | CN | claimed |
| CN-115044073-B | Preparation method and application of nano copper antibacterial and antiviral master batch | 浙江理工大学 | 2025-02-18 | — | — | CN | claimed |
| CN-116479544-B | Preparation method of efficient antibacterial and antiviral functional fiber | 浙江理工大学 | 2025-01-17 | — | — | CN | claimed |
| CN-118767167-A | Metal organic framework carrier for tumor multi-mode treatment and preparation method and application thereof | 青岛科技大学 | 2024-10-15 | — | — | CN | claimed |
| EP-0656000-A4 | PROCESS OF CONVERTING TAXANES INTO BACCATIN III AND 10-DEACETYLBACCATIN III. | NAPRO BIOTHERAPEUTICS INC (US) | 1995-07-19 | — | — | EP | claimed |
| EP-0656000-A1 | PROCESS OF CONVERTING TAXANES INTO BACCATIN III AND 10-DEACETYLBACCATIN III | NAPRO BIOTHERAPEUTICS, INC. (US) | 1995-06-07 | — | — | EP | claimed |
| EP-0600517-A1 | 6,7-Modified paclitaxels | Bristol-Myers Squibb Company (US) | 1994-06-08 | — | — | EP | claimed |
| WO-1994004519-A1 | PROCESS OF CONVERTING TAXANES INTO BACCATIN III AND 10-DEACETYLBACCATIN III | NAPRO BIOTHERAPEUTICS, INC. (US) | 1994-03-03 | — | — | WO | claimed |
| US-5202448-A | Hydrolysis of the ester at the C-13 position using a borohydride reducing salt in the presence of a Lewis Acid in a solvent | NAPRO BIOTHERAPEUTICS, INC. (US) | 1993-04-13 | — | — | US | claimed |
| US-5197996-A | Discoloration inhibition | BETZ LABORATORIES, INC. (US) | 1993-03-30 | — | — | US | claimed |
| EP-0221996-B1 | SUBSTITUTED 2,3-DIHYDRO-6-HYDROXY-PYRIMIDO [2,1-f] PURINE-4,8(1H,9H)-DIONES | SCHERING CORPORATION (US) | 1990-08-29 | — | — | EP | claimed |
| EP-0221996-A1 | SUBSTITUTED 2,3-DIHYDRO-6-HYDROXY-PYRIMIDO [2,1-f] PURINE-4,8(1H,9H)-DIONES. | SCHERING CORP (US) | 1987-05-20 | — | — | EP | claimed |
| US-4631205-A | Process for producing coherent films of polyacetylene | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-12-23 | — | — | US | claimed |
| WO-1986006724-A1 | SUBSTITUTED 2,3-DIHYDRO-6-HYDROXY-PYRIMIDO AD2,1-f BD-PURINE-4,8(1H,9H)-DIONES | SCHERING CORPORATION (US) | 1986-11-20 | — | — | WO | claimed |